Beta-2 glycoprotein I and its role in antiphospholipid syndrome - Lessons from knockout mice

Clinical Immunology

Volumn 112, Issue 2, 2004, Pages 136-143

  Miyakis, Spiros ^a   Robertson, Sarah A ^b   Krilis, Steven A ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Antiphospholipid syndrome; Autoantibodies; Mice; Pregnancy loss; Thrombin; Transgenic or knockout; 2 glycoprotein I

Indexed keywords

BETA2 GLYCOPROTEIN 1; THROMBIN;

ANTIPHOSPHOLIPID SYNDROME; BLOOD CLOTTING; FEMALE FERTILITY; FETUS WASTAGE; GENE DELETION; GESTATION PERIOD; HOMOZYGOSITY; IMPLANTATION; IN VITRO STUDY; KNOCKOUT MOUSE; MORPHOGENESIS; MOUSE; NONHUMAN; PATHOGENESIS; PLACENTA; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SEQUENCE HOMOLOGY;

EID: 3042828421     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clim.2004.02.014     Document Type: Article

References (88)

1. Kandiah D.A., Sali A., Sheng Y., Victoria E.J., Marquis D.M., Coutts S.M., Krilis S.A. Current insights into the "antiphospholipid" syndrome: clinical, immunological, and molecular aspects. Adv. Immunol. 70:1998;507-563
2. Alarcon-Segovia D., Perez-Vazquez M.E., Villa A.R., Drenkard C., Cabiedes J. Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus. Semin. Arthritis Rheum. 21:1992;275-286
3. Asherson R.A., Khamashta M.A., Ordi-Ros J., Derksen R.H.M.W., Machin S.J., Barquinero J., Outt H.H., Harris E.N., Vilardell-Torres M., Hughes G.R.V. The "primary" antiphospholipid syndrome: major clinical and serological features. Medicine. 68:1989;366-374
4. Langer F., Eifrig B., Marx G., Stork A., Hegewisch-Becker S., Hossfeld D.K. Exacerbation of antiphospholipid antibody syndrome after treatment of localized cancer: a report of two cases. Ann. Hematol. 81:2002;727-731
5. Santiago M., Martinelli R., Ko A., Reis E.A., Fontes R.D., Nascimento E.G., Pierangeli S., Espinola R., Gharavi A. Anti-beta2 glycoprotein I and anticardiolipin antibodies in leptospirosis, syphilis and kala-azar. Clin. Exp. Rheumatol. 19:2001;425-430
6. McNeil H.P., Simpson R.J., Chesterman C.N., Krilis S.A. Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). Proc. Natl. Acad. Sci. U.S.A. 87:1990;4120-4124
7. Helbert M., Bodger S., Cavenagh J., D'Cruz D., Thomas J.M., MacCallum P. Optimising testing for phospholipid antibodies. J. Clin. Pathol. 54:2001;693-698
8. Audrain M.A., El-Kouri D., Hamidou M.A., Mioche L., Ibara A., Langlois M.L., Muller J.Y. Value of autoantibodies to beta(2)-glycoprotein 1 in the diagnosis of antiphospholipid syndrome. Rheumatology. 41:2002;550-553
9. Hunt J.E., McNeil H.P., Morgan G.J., Crameri R.M., Krilis S.A. A phospholipid-beta 2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection. Lupus. 1:1992;75-81
10. Galli M., Comfurius P., Barbui T., Zwaal R.F., Bevers E.M. Anticoagulant activity of beta 2-glycoprotein I is potentiated by a distinct subgroup of anticardiolipin antibodies. Thromb. Haemost. 68:1992;297-300
11. Roubey R.A., Pratt C.W., Buyon J.P., Winfield J.B. Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent upon beta 2-glycoprotein I. J. Clin. Invest. 90:1992;1100-1104
12. 2-glycoprotein I. Proc. Natl. Acad. Sci. U.S.A. 81:1984;3640-3644
13. 2- glycoprotein I. Biochem. J. 277:1991;387-391
14. Patthy L. Detecting homology of distantly related proteins with consensus sequences. J. Mol. Biol. 198:1987;567-577
15. Kiato H., Enjyoji K. Amino acid sequence and location of the bisulfide bonds in bovine beta 2 glycoprotein I: the presence of five Sushi domains. Biochemistry. 30:1991;11687-11694
16. 2-glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome. EMBO J. 18:1999;6228-6239
17. 2-glycoprotein I to phospholipids based on its crystal structure. EMBO J. 18:1999;5166-5174
18. 2GPI. Proc. Natl. Acad. Sci. U.S.A. 95:1998;15542-15546
19. 2GPI in antibody binding. J. Immunol. 160:1998;3917-3923
20. 2-glycoprotein I identifies a cluster of lysine residues that are critical for phospholipid binding and anti-cardiolipin antibody activity. J. Immunol. 157:1996;3744-3751
21. 2-glycoprotein I critical for lipid binding and anti-cardiolipin antibody cofactor activity. Proc. Natl. Acad. Sci. U.S.A. 90:1993;2141-2145
22. Ohkura N., Hagihara Y., Yoshimura T., Goto Y., Kato H. Plasmin can reduce the function of human beta2 glycoprotein I by cleaving domain V into a nicked form. Blood. 91:1998;4173-4179
23. Sanghera D.K., Wagenknecht D.R., McIntyre J.A., Kamboh M.I. Identification of structural mutations in the fifth domain of apolipoprotein H (beta 2-glycoprotein I) which affect phospholipid binding. Hum. Mol. Genet. 6:1997;311-316
24. Guerin J., Sheng Y., Reddel S., Iverson G.M., Chapman M.G., Krilis S.A. Heparin inhibits the binding of beta 2-glycoprotein I to phospholipids and promotes the plasmin-mediated inactivation of this blood protein. Elucidation of the consequences of the two biological events in patients with the anti-phospholipid syndrome. J. Biol. Chem. 277:2002;2644-2649
25. 2-glycoprotein-1 and the influence of plasma lipids. Thromb. Res. 72:1993;275-286
26. Mehdi H., Aston C.E., Sanghera D.K., Hamman R.F., Kamboh M.I. Genetic variation in the apolipoprotein H (beta2-glycoprotein I) gene affects plasma apolipoprotein H concentrations. Hum. Genet. 105:1999;63-71
27. Mehdi H., Manzi S., Desai P., Chen Q., Nestlerode C., Bontempo F., Strom S.C., Zarnegar R., Kamboh M.I. A functional polymorphism at the transcriptional initiation site in beta2-glycoprotein I (apolipoprotein H) associated with reduced gene expression and lower plasma levels of beta2-glycoprotein I. Eur. J. Biochem. 270:2003;230-238
28. 2-Glycoprotein I. Molecular properties of an unusual apolipoprotein, apolipoprotein H. J. Biol. Chem. 258:1983;4765-4770
29. 2-glycoprotein I). Biochem. Biophys. Res. Commun. 95:1980;1168-1172
30. Averna M., Paravizzini G., Marino G., Lanteri E., Cavera G., Barbagallo C.M., Petralia S., Cavallaro S., Magro G., Grasso S., Notarbartolo A., Travali S. Liver is not the unique site of synthesis of beta 2-glycoprotein I (apolipoprotein H): evidence for an intestinal localization. Int. J. Clin. Lab. Res. 27:1997;207-212
31. Chamley L.W., Allen J.L., Johnson P.M. Synthesis of beta2 glycoprotein 1 by the human placenta. Placenta. 18:1997;403-410
32. Reddel S.W., Krilis S.A. The anti-phospholipid syndrome. Theofilopoulos A.N., Bona C.A. The Molecular Pathology of Autoimmune Diseases. second ed. 2002;325-352 Taylor and Francis, New York
33. Hoeg J.M., Segal P., Gregg R.E., Chang Y.S., Lindgren F.T., Adamson G.L., Frank M., Brickman C., Brewer H.B. Jr. Characterization of plasma lipids and lipoproteins in patients with beta 2-glycoprotein I (apolipoprotein H) deficiency. Atherosclerosis. 55:1985;25-34
34. Yasuda S., Tsutsumi A., Chiba H., Yanai H., Miyoshi Y., Takeuchi R., Horita T., Atsumi T., Ichikawa K., Matsuura E., Koike T. Beta(2)-glycoprotein I deficiency: prevalence, genetic background and effects on plasma lipoprotein metabolism and hemostasis. Atherosclerosis. 152:2000;337-346
35. Nimpf J., Bevers E.M., Bomans P.H., Till U., Wurm H., Kostner G.M., Zwaal R.F. Prothrombinase activity of human platelets is inhibited by beta 2-glycoprotein-I. Biochim. Biophys. Acta. 884:1986;142-149
36. 2-Glycoprotein I modulates the anticoagulant activity of activated protein C on the phospholipid surface. Thromb. Haemost. 75:1996;49-55
37. 2- glycoprotein I with human blood platelets: influences upon the ADP induced aggregation. Thromb. Haemost. 54:1985;397-401
38. 2-glycoprotein I of the factor Xa generating activity of platelets. Thromb. Haemost. 70:1993;342-345
39. Amengual O., Atsumi T., Khamashta M.A., Hughes G.R.V. The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome. Thromb. Haemost. 79:1998;276-281
40. Ieko M., Ichikawa K., Triplett D.A., Matsuura E., Atsumi T., Sawada K., Koike T. Beta2-glycoprotein I is necessary to inhibit protein C activity by monoclonal anticardiolipin antibodies. Arthritis Rheum. 42:1999;167-174
41. Takeuchi R., Atsumi T., Ieko M., Takeya H., Yasuda S., Ichikawa K., Tsutsumi A., Suzuki K., Koike T. Coagulation and fibrinolytic activities in 2 siblings with beta2-glycoprotein I deficiency. Blood. 96:2000;1594-1595
42. Oosting J.D., Derksen R.H., Bobbink I.W., Hackeng T.M., Bouma B.N., de Groot P.G. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism? Blood. 81:1993;2618-2625
43. Galli M., Ruggeri L., Barbui T. Differential effects of anti-beta2-glycoprotein I and antiprothrombin antibodies on the anticoagulant activity of activated protein C. Blood. 91:1998;1999-2004
44. Schousboe I., Rasmussen M.S. Synchronized inhibition of the phospholipid mediated autoactivation of factor XII in plasma by b2-glycoprotein I and anti-b2-glycoprotein I. Thromb. Haemost. 73:1995;798-804
45. Takeuchi R., Atsumi T., Ieko M., Amasaki Y., Ichikawa K., Koike T. Suppressed intrinsic fibrinolytic activity by monoclonal anti-beta-2 glycoprotein I autoantibodies: possible mechanism for thrombosis in patients with antiphospholipid syndrome. Br. J. Haematol. 119:2002;781-788
46. Jones D.W., MacKie I.J., Gallimore M.J., Winter M. Antibodies to factor XII and recurrent fetal loss in patients with the anti-phospholipid syndrome. Br. J. Haematol. 113:2001;550-552
47. Nojima J., Kuratsune H., Suehisa E., Futsukaichi Y., Yamanishi H., Machii T., Iwatani Y., Kanakura Y. Association between the prevalence of antibodies to beta(2)-glycoprotein I, prothrombin, protein C, protein S, and annexin V in patients with systemic lupus erythematosus and thrombotic and thrombocytopenic complications. Clin. Chem. 47:2001;1008-1015
48. Chamley L.W., Duncalf A.M., Mitchell M.D., Johnson P.M. Action of anticardiolipin and antibodies to beta2-glycoprotein-I on trophoblast proliferation as a mechanism for fetal death. Lancet. 352:1998;1037-1038
49. Sthoeger Z.M., Mozes E., Tartakovsky B. Anti-cardiolipin antibodies induce pregnancy failure by impairing embryonic implantation. Proc. Natl. Acad. Sci. U.S.A. 90:1993;6464-6467
50. 2-glycoprotein I). Biochem. Biophys. Res. Commun. 95:1980;1168-1172
51. Chappel D.A., Spector A.A. Lipoprotein and lipid metabolism: basis and clinical aspects. Redmond G.P. Lipids and Women's Health. 1991;21-38 Springer-Verlag, New York
52. 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J. Exp. Med. 179:1994;457-462
53. 2-glycoprotein I and anticardiolipin antibodies in oxidatively modified low-density lipoprotein uptake by macrophages. Clin. Exp. Immunol. 107:1997;569-573
54. Redman C.W. Pre-eclampsia and the placenta. Placenta. 12:1991;301-308
55. Riboldi P., Gerosa M., Raschi E., Testoni C., Meroni P.L. Endothelium as a target for antiphospholipid antibodies. Immunobiology. 207:2003;29-36
56. Raschi E., Testoni C., Bosisio D., Borghi M.O., Koike T., Mantovani A., Meroni P.L. Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies. Blood. 101:2003;3495-3500
57. Branch D.W., Dudley D.J., Mitchell M.D., Creighton K.A., Abbott T.M., Hammond E.H., Daynes R.A. Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BALB/c mice: a model for autoimmune fetal loss. Am. J. Obstet. Gynecol. 163:1990;210-216
58. Blank M., Cohen J., Toder V., Shoenfeld Y. Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. Proc. Natl. Acad. Sci. U.S.A. 88:1991;3069-3073
59. Chamley L.W., Pattison N.S., McKay E.J. The effect of human anticardiolipin antibodies on murine pregnancy. J. Reprod. Immunol. 27:1994;123-134
60. Silver R.M., Pierangeli S.S., Gharavi A.E., Harris E.N., Edwin S.S., Salafia C.M., Branch D.W. Induction of high levels of anticardiolipin antibodies in mice by immunization with beta 2-glycoprotein I does not cause fetal death. Am. J. Obstet. Gynecol. 173:1995;1410-1415
61. Garcia C.O., Kanbour-Shakir A., Tang H., Molina J.F., Espinoza L.R., Gharavi A.E. Induction of experimental antiphospholipid antibody syndrome in PL/J mice following immunization with beta 2 GPI. Am. J. Reprod. Immunol. 37:1997;118-124
62. Holers V.M., Girardi G., Mo L., Guthridge J.M., Molina H., Pierangeli S.S., Espinola R., Xiaowei L.E., Mao D., Vialpando C.G., Salmon J.E. Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J. Exp. Med. 195:2002;211-220
63. 2- glycoprotein-I in 500 women with recurrent miscarriage: results of a comprehensive screening approach. Hum. Reprod. 10:1995;2001-2005
64. Pattison N.S., Chamley L.W., McKay E.J., Liggins G.C., Butler W.S. Antiphospholipid antibodies in pregnancy: prevalence and clinical associations. Br. J. Obstet. Gynaecol. 100:1993;909-913
65. Bagger P.V., Andersen V., Baslund B., Beck B., Hove H., Hoier-Madsen M., Petersen J., Philip J., Schaadt O., Skouby S.O. Anti-cardiolipin antibodies (IgG and IgA) in women with recurrent fetal loss correlate to clinical and serological characteristics of SLE. Acta Obstet. Gynecol. Scand. 72:1993;465-469
66. Theofilopoulos A.N., Dixon F.J. Murine models of systemic lupus erythematosus. Adv. Immunol. 37:1985;269-390
67. Koike T. Anticardiolipin antibodies in NZW × BXSB F1 mice. Lupus. 3:1994;241-246
68. 2-glycoprotein I and cardiolipin. Species specificity and charge-dependent binding. J. Immunol. 156:1996;2631-2641
69. Cohen M.G., Pollard K.M., Schrieber L. Relationship of age and sex to autoantibody expression in MRL-+/+ and MRL-lpr/lpr mice: demonstration of an association between the expression of antibodies to histones, denatured DNA and Sm in MRL-+/+ mice. Clin. Exp. Immunol. 72:1988;50-54
70. Gharavi A.E., Mellors R.C., Elkon K.B. IgG anti-cardiolipin antibodies in murine lupus. Clin. Exp. Immunol. 78:1989;233-238
71. Mendlovic S., Brocke S., Shoenfeld Y., Ben-Bassat M., Meshorer A., Bakimer R., Mozes E. Induction of a systemic lupus erythematosus-like disease in mice by a common human anti-DNA idiotype. Proc. Natl. Acad. Sci. U.S.A. 85:1988;2260-2264
72. Blank M., Cohen J., Toder V., Shoenfeld Y. Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. Proc. Natl. Acad. Sci. U.S.A. 88:1991;3069-3073
73. Isenberg D.A., Katz D., Le Page S., Knight B., Tucker L., Maddison P., Hutchings P., Watts R., Andre-Schwartz J., Schwartz R.S. Independent analysis of the 16/6 idiotype lupus model. A role for an environmental factor? J. Immunol. 147:1991;4172-4177
74. Pierangeli S.S., Harris E.N. Antiphospholipid antibodies in an in vivo thrombosis model in mice. Lupus. 3:1994;247-251
75. Pierangeli S.S., Espinola R., Liu X., Harris E.N., Salmon J.E. Identification of an Fc gamma receptor-independent mechanism by which intravenous immunoglobulin ameliorates antiphospholipid antibody-induced thrombogenic phenotype. Arthritis Rheum. 44:2001;876-883
76. 2-glycoprotein I. Genomics. 41:1997;128-130
77. Ma K., Simantov R., Zhang J.C., Silverstein R., Hajjar K.A., McCrae K.R. High affinity binding of beta 2-glycoprotein I to human endothelial cells is mediated by annexin II. J. Biol. Chem. 275:2000;15541-15548
78. 2-glycoprotein I mediated by the kringle IV domain. Blood. 90:1997;1482-1489
79. 2- glycoprotein I (apolipoprotein H). J. Clin. Invest. 90:1992;1105-1109
80. Tincani A., Gilburd B., Abu-Shakra M., Blank M., Allegri F., Ottaviani R., Riboni M., Meroni P.L., Balestrieri G., Shoenfeld Y. Immunization of naive BALB/c mice with human beta2-glycoprotein I breaks tolerance to the murine molecule. Arthritis Rheum. 46:2002;1399-1404
81. Gharavi E.E., Chaimovich H., Cucurull E., Celli C.M., Tang H., Wilson W.A., Gharavi A.E. Induction of antiphospholipid antibodies by immunization with synthetic viral and bacterial peptides. Lupus. 8:1999;449-455
82. Blank M., Krause I., Fridkin M., Keller N., Kopolovic J., Goldberg I., Tobar A., Shoenfeld Y. Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome. J. Clin. Invest. 109:2002;797-804
83. 2- glycoprotein I null mice. J. Biol. Chem. 276:2001;13817-13821
84. Zumbach A., Marbet G.A., Tsakiris D.A. Influence of the genetic background on platelet function, microparticle and thrombin generation in the common laboratory mouse. Platelets. 12:2001;496-502
85. Bishop J.B., Morris R.W., Seely J.C., Hughes L.A., Cain K.T., Generoso W.M. Alterations in the reproductive patterns of female mice exposed to xenobiotics. Fundam. Appl. Toxicol. 40:1997;191-204
86. Rand M.D., Lock J.B., van't Veer C., Gaffney D.P., Mann K.G. Blood clotting in minimally altered whole blood. Blood. 88:1996;3432-3445
87. Hanly J.G., Kandiah D., Kouts S., Sheng Y., Koike T., Ichikawa K., Monestier M., Krilis S. Detection of "antiphospholipid antibodies" using a chromogenic assay of thrombin generation. Lupus. 7:1998;S219
88. Lieby P., Soley A., Levallois H., Hugel B., Freyssinet J.M., Cerutti M., Pasquali J.L., Martin T. The clonal analysis of anticardiolipin antibodies in a single patient with primary antiphospholipid syndrome reveals an extreme antibody heterogeneity. Blood. 97:2001;3820-3828